drugset / Trial / NCT01613807

Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes

NCT01613807

RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluation of the Safety and Efficacy of Humalog® Mix50/50TM administered as 3 injections daily to Humalog® plus Humulin N® insulin administered as 6 separate injections daily in terms of glucose control for women with Gestational Diabetes.

Timeline

Start
2008-10
Primary completion
2010-06
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic
Subject Insulin Lispro Protein / enzyme biologic

Indications